Skip to main content

Table 7 Analysis of maximum likelihood estimates under Cox's model.

From: Inhibitors of apoptosis proteins in human cervical cancer

Factor

Hazard ratio (95% CI)

p

(A) Univariate analysis of disease-free survival

FIGO stage

2.41 (1.10–5.00)

0.018

Age

1.00 (0.97–1.00)

0.075

Menopause

0.77 (0.46–1.31)

0.063

Histology

2.58 (1.24–5.41)

0.011

Survivin

0.99 (0.99–1.00)

0.295

Survivin2B

1.00 (0.99–1.01)

0.592

SurvivinΔEx3

1.00 (0.99–1.02)

0.187

XIAP

0.69 (0.59–0.94)

0.048

c-IAP1

0.99 (0.98–1.01)

0.334

c-IAP2

0.98 (0.96–1.00)

0.115

(B) Multivariate Cox model of disease-free survival

FIGO stage

3.13 (1.11–8.81)

0.031

Age

1.06 (0.98–1.13)

0.108

Menopause

0.29 (0.07–1.20)

0.089

Histology

1.77 (0.71–4.41)

0.071

Survivin

0.97 (0.99–1.00)

0.374

Survivin2B

1.00 (0.07–1.03)

0.743

SurvivinΔEx3

0.99 (0.07–1.02)

0.882

XIAP

0.79 (0.69–0.96)

0.516

c-IAP1

0.99 (0.97–1.01)

0.548

c-IAP2

0.99 (0.98–1.00)

0.486